Skip to content

Funds of $150 Million Secured for CARE Healthcare Foundation's Operational Model

Healthcare tech firm Aidoc obtains $150 million for its initiative, CARE, aimed at enhancing diagnostic decisions for 100 million patients. This acquisition, headed by General Catalyst and Square Peg, escalates Aidoc's total funds to $370 million and facilitates the advancement and expansion of...

Funding of $150 Million Secured for CARE Healthcare Foundation's Operational Model
Funding of $150 Million Secured for CARE Healthcare Foundation's Operational Model

Funds of $150 Million Secured for CARE Healthcare Foundation's Operational Model

Aidoc Secures $150 Million for Healthcare AI Model, CARE

Aidoc, a leading AI company in healthcare, has announced a significant investment of $150 million for its Healthcare Foundation Model, CARE. This funding is aimed at accelerating the development and market expansion of CARE.

CARE, a clinical-grade foundation model, is designed to revolutionize AI usage in healthcare. Integrated into Aidoc's enterprise-grade AI operating system, aiOS, CARE aims to cover 90% of clinically relevant diseases within three years. The goal is to transform clinical decision-making for 100 million patients, supporting the transition from reactive to proactive, personalized care.

The platform, already serving over 45 million patients across 150+ health systems, has received FDA clearance. Aidoc's solutions have enabled the efficient analysis of thousands of images per case, leading to a significant reduction of critical diagnosis delays. This is evident in partnerships with health systems like Advocate Health and Sutter Health, where CARE has demonstrated its clinical impact by helping radiologists analyze large volumes of imaging cases.

The aiOS platform, hosting both Aidoc and third-party AI models, shows broad interoperability. In fact, 69% of customers are already leveraging non-Aidoc models. Strategic collaborations with Amazon Web Services and Nvidia provide strong technical foundations, including high-performance computing and the development of AI implementation standards (BRIDGE guidelines).

Elad Walach, CEO of Aidoc, envisions a future of healthcare grounded in trust, innovation, and compassion. He believes that CARE, much like ChatGPT in general use, will facilitate more accurate, timely, and scalable clinical decisions, fostering widespread AI adoption in health systems through an open, interoperable platform infrastructure.

The funding brings Aidoc's total to $370 million. Notable partnerships include Hartford HealthCare, which has a Centre for AI Innovation in Healthcare and is collaborating with Aidoc. In one year, Aidoc has helped Hartford HealthCare radiologists analyze over 200,000 cases. Jeffrey A. Flaks, President and CEO of Hartford HealthCare, believes Aidoc is an important partner in their commitment to improve patient outcomes and stay at the forefront of tech-powered healthcare transformation.

Roxanna Gapstur, CEO of WellSpan Health, emphasizes the importance of model accuracy in healthcare and believes foundation models will soon be as ubiquitous as ChatGPT. She also highlights that scaling clinical AI requires top-tier talent, powerful infrastructure, deep real-world insight, and sustained funding. The investment in CARE marks a significant advancement in the integration and impact of clinical AI.

[1] Aidoc Press Release, [Date], [Link] [2] Aidoc Blog Post, [Date], [Link] [3] Aidoc Case Study, [Date], [Link]

  1. The $150 million investment in Aidoc's CARE model will not only boost the development and market expansion of this clinical-grade AI, but it will also facilitate more accurate, timely, and scalable clinical decisions, similar to the widespread adoption of ChatGPT in general use.
  2. As Aidoc continues to develop and integrate technology like CARE into their enterprise-grade AI operating system, aiOS, they are making strategic strides toward transforming the healthcare business landscape, particularly by supporting the transition from reactive to proactive, personalized care for up to 100 million patients.

Read also:

    Latest